Combination Ketamine and Propofol vs Propofol for Emergency Department Sedation: A Prospective Randomized Trial



Status:Completed
Conditions:Hospital
Therapuetic Areas:Other
Healthy:No
Age Range:18 - Any
Updated:2/7/2015
Start Date:June 2010
End Date:June 2013
Contact:Virgil Davis, MD
Email:Virgil.Davis@hsc.utah.edu
Phone:8015812417

Use our guide to learn which trials are right for you!

The purpose of this study is to determine if procedural sedation utilizing a 1:1 mixture of
propofol and ketamine is equivalent in complications, patient and physician satisfaction,
post-procedure pain level, and procedural outcome to propofol sedation alone.

Procedural sedation (PS) is common in the Emergency Department (ED) for painful or
anxiety-producing procedures. In our ED these procedures commonly include fracture and
dislocation management and reduction, abscess incision and drainage, lumbar puncture,
extensive wound debridement, dilatation and curettage, chest tube placement and
cardioversion. Generally a sedative-hypnotic agent is combined with an analgesic in order
to provide this sedation. The ideal agents to utilize remain unclear. The ED environment
is substantially different than the operative suite or many outpatient areas and literature
from these areas has limited applicability.

In many ED's, including our own, propofol combined with either a short acting or long acting
narcotic has become very commonly utilized. Propofol has many advantages including rapid
onset, rapid recovery, strong sedative and amnestic properties, and euphoric effects.
However like many sedative-hypnotics it possesses strong respiratory depressive properties
and has cardio-depressant and vasodilatation effects that can lead to hypotension. These
effects can be potentiated by concomitant narcotic administration as opioid agonists posses
similar properties.2

ED literature on complications associated with propofol sedation is variable, secondary to
significant differences in rapidity of administration of the medication, the type of
analgesic provided, the definitions of complications, the amount of pre-oxygenation
provided, and the variability in experience of medical providers. Most literature suggests
that the overall rate of sub-clinical respiratory depression, measured by indicators such as
end-tidal CO2 changes, is approximately 30-40% of patients1-3. The clinical importance of
these changes is unclear. Clinical respiratory depression, measure by hypoxemia, need for
verbal or tactile stimulation, bag valve mask ventilation (BVM), and airway positioning, is
reported in 1-25% of patients, with the need for BVM ranging from 0-4.6% of patients1-6. It
is noteworthy that one study, utilizing a slow infusion rate and only long-acting narcotics
administered greater than 20 minutes prior to the start of sedation, prospectively
demonstrated only a 0.88% rate of hypoxemia and a 0% rate of BVM while maintaining a similar
total average dose, patient satisfaction, and successful outcome6. However this has not
been replicated, and the data from other ED studies seems to suggest rates of clinical
respiratory depression of 10-12% with BVM use averaging 4%1-6. The only clear conclusion to
be drawn from the medical literature in this regard is that some respiratory depression and
need for airway management can occur, but the rate is likely heavily dependent on exact
protocols and definitions, make comparison between centers and studies difficult.

Because of interest in developing effective sedation regimens that might mitigate some of
the complications of propofol plus narcotic regimens (hereafter termed propofol sedation), a
technique of combining propofol and ketamine has been described for use in the ED. This
combination is long-standing in some settings 7-10 and its use in the ED has been described
9,12,13. Ketamine is a dissociative hypnotic that acts by binding N-methyl-D-aspartate
(NMDA) receptors, blocking their excitatory function. It has analgesic, amnestic, and
dissociative, effects 9-12. It has the beneficial properties of maintaining respiratory
drive, maintaining muscular airway control while still providing pain relief and
dissociation. Its use as a single agent for ED sedation in adults has been limited by
concern about dysphoria at anesthetic doses as well as post-sedation nausea and vomiting.
It can also cause tachycardia and hypertension. However the intuitive off-setting of the
somewhat opposite side effects of propofol and ketamine have created significant interest in
sedation regimens utilizing both agents. (ie propofol decrease heart rate (HR), blood
pressure (BP), respiratory drive and airway maintenance, is euphoric and is an anti-emetic.
Ketamine increases HR, BP and increases or maintains respiratory drive and airway
maintenance, but is dysphoric and can be nauseating.) An ED study was published in 2007
describing the use of a fixed dose mixture of 1:1 propofol and ketamine (also termed
"Ketofol") in a single syringe, allowing for easy dose titration 12. This study showed high
patient and physician satisfaction (mean of 10 on a 1-10 scale), high rates of procedural
success, and an extremely low rate of complications (2.5% rate of hypoxemia, 0.9% rate of
BVM ventilation)12. Another study, in children with different dosing parameters, recently
suggested a similarly low rate of BVM (0%) but a higher rate of respiratory depression
(15%)13. Interestingly this study used a lower amount of ketamine and higher dose of
propofol, which perhaps contributed to the increased rate of respiratory depression.
Retrospective data from our use of fixed dose 1:1 ketamine and propofol demonstrates a
similar safety profile with 7% of patients having some respiratory depression or requiring
airway management and an absolute rate of 2% requiring BVM. We have commonly used this
combination in our ED since 2007.

Currently in our ED both propofol sedation and ketamine plus propofol sedation are variably
employed, depending mainly on prescriber preference. Because the literature has significant
variability in the reported complication rates of the two regimens, no firm conclusion is
possible about the relative equivalence or superiority of one regimen compared to the other.
Attending physician preference currently dictates the choice of an agent for our patients
in lieu of any robust evidence to guide our selection. Further, there is no data to measure
the relative patient satisfaction and provider ease of utilization of either of these
regimens, important factors in the selection of sedation agents.

We plan to conduct a prospective, randomized, equivalence trial of a fixed ratio of 1:1
ketamine and propofol vs propofol alone sedation. We will measure sub-clinical and clinical
respiratory depression, the need for active airway management, unpleasant complications such
as post-sedation nausea and vomiting, dysphoria and emergence reactions, patient and
provider satisfaction, and post-procedure and follow up pain.

Inclusion Criteria:

- English speaking patients eighteen and older who present to the University of Utah
Emergency Department and require, in their treating physician's opinion, procedural
sedation for a procedure or radiologic study performed in the Emergency Department.

Exclusion Criteria:

- Include prior sensitization or allergic reaction to propofol, ketamine, soy or egg
products; hemodynamic instability; clinical evidence of head injury, increased
intracranial or intraocular pressure; use of drugs known to interact with either
study agent, pregnancy with a live intra-uterine pregnancy (i.e. undergoing Dilation
and Curettage for intrauterine fetal demise or spontaneous abortion is not an
exclusion criteria).
We found this trial at
1
site
201 Presidents Circle
Salt Lake City, Utah 84108
801) 581-7200
University of Utah Research is a major component in the life of the U benefiting...
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials